Company / Shares Outstanding
Candel Therapeutics, Inc. Shares Outstanding History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
28.9M
FY2023
5-year range
11.6M / 28.9M
FY2021-FY2023
Trend
+0.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 11635094.00 to 28919810.00 over the past 2 years.
Based on SEC 10-K filings.
28919810.00 in FY2023.
Increased from 11635094.00 to 28919810.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, shares outstanding increased 0.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | 28.9M | +0.8% |
| FY2022 | 28.7M | +146.6% |
| FY2021 | 11.6M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026